MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

11 Jul 2023 Evaluate
The total revenue hovered 114.01% to Rs. 65.08 millions for the June 2023 quarter as against Rs. 30.41 millions during the corresponding quarter last year.A slender decline of -4.76% was recorded to Rs. 0.80  millions from Rs. 0.84 millions in the corresponding previous quarter.Operating profit for the quarter ended June 2023 decreased to 3.03 millions as compared to 3.57 millions of corresponding quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 65.08 30.41 114.01 65.08 30.41 114.01 183.21 254.32 -27.96
Other Income 0.27 2.35 -88.51 0.27 2.35 -88.51 8.55 6.53 30.93
PBIDT 3.03 3.57 -15.13 3.03 3.57 -15.13 18.10 19.68 -8.03
Interest 0.34 0.88 -61.36 0.34 0.88 -61.36 1.50 4.64 -67.67
PBDT 2.69 2.69 0.00 2.69 2.69 0.00 16.60 15.04 10.37
Depreciation 1.60 1.57 1.91 1.60 1.57 1.91 6.33 5.62 12.63
PBT 1.09 1.12 -2.68 1.09 1.12 -2.68 10.27 9.42 9.02
TAX 0.29 0.28 3.57 0.29 0.28 3.57 2.57 2.36 8.90
Deferred Tax 0.29 0.28 3.57 0.29 0.28 3.57 2.09 2.34 -10.68
PAT 0.80 0.84 -4.76 0.80 0.84 -4.76 7.70 7.06 9.07
Equity 83.16 83.16 0.00 83.16 83.16 0.00 83.16 83.16 0.00
PBIDTM(%) 4.66 11.74 -60.34 4.66 11.74 -60.34 9.88 7.74 27.67
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..